Latest Breaking News On - Chief biopharma business officer - Page 1 : vimarsana.com

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator

BOSTON & PRINCETON, N.J. (BUSINESS WIRE) May 29, 2024

United statesNew jerseyArnold levineFoundationone cdxKathy vincentTroy schurrDanielle johnsTim smithPharmaceuticals incFoundation medicine incGreig communicationsFoundation medicineFlatiron healthDrug administrationFoundation medicine commercial tissue or hemeFoundation medicine clinico

AnHeart Therapeutics and Foundation Medicine Announce Collaboration to Develop Tissue-Based and Liquid-Based Companion Diagnostics for Taletrectinib, a ROS1 Inhibitor

AnHeart Therapeutics and Foundation Medicine Announce Collaboration to Develop Tissue-Based and Liquid-Based Companion Diagnostics for Taletrectinib, a ROS1 Inhibitor
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkTroy schurrFoundationone cdxFoundation medicineFoundation medicine announce collaboration to develop tissueChina national medical products administrationDrug administrationFoundation medicine incHeart therapeuticsFoundation medicine announce collaborationDevelop tissue basedLiquid based companion diagnosticsBreakthrough therapy designationChief biopharma business officerIntended use

U S FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca s Truqaptm (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer

U S FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca s Truqaptm (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca truqapFoundationone cdxShehzin tietjenTroy schurrAstrazeneca truqaptmDrug administrationFoundation medicine incProduct serviceFoundation medicineCompanion diagnosticIdentify patientsNegative advanced breastChief biopharma business officerAssociate directorCorporate relationsLiving beyond breast

Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories to Develop Companion Diagnostics in Non-Small Cell Lung Cancer

Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories to Develop Companion Diagnostics in Non-Small Cell Lung Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMidi pyréesLaure sgandurraFoundationone cdxPierre fabreAbigail linehanTroy schurrFoundation medicine incEuropean unionDrug administrationFoundation medicineAmerican cancer societyPatient consumer departmentEuropean medicines agencyPierre fabre foundation

Foundation Medicine Expands Partnership with Sequanta to Provide both Liquid and Tissue Genomic Profiling Services in China to Support Global Regulatory Filings

Foundation Medicine Expands Partnership with Sequanta to Provide both Liquid and Tissue Genomic Profiling Services in China to Support Global Regulatory Filings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomFoundationone cdxHolly campbellLele sunTroy schurrFoundation medicine incFoundation medicineSequanta technologies co ltdUnites statesFoundationone liquidChief biopharma business officerIntended useEssential partnerCancer careOlink target